Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 47Neoplasms, Plasma Cell 13Lymphoma 6Lymphoma, Non-Hodgkin 5Leukemia 5Hodgkin Disease 5Myeloproliferative Disorders 4Myelodysplastic Syndromes 4Leukemia, Lymphocytic, Chronic, B-Cell 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Hematologic Neoplasms 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 2Sarcoma, Clear Cell 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Primary Myelofibrosis 2Neurofibrosarcoma 2Nerve Sheath Neoplasms 2Neoplasms 2Lymphoma, Mantle-Cell 2

Interventions

Thalidomide 1Melphalan 1Etoposide 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polyneuropathies × Doxorubicin × Plasma cell × Clear all
NCT01548573 2017-06-14

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

University of Iowa

Phase 2 Terminated
19 enrolled 7 charts
Plasma cell

Amyloidosis, Endocrine System Diseases, Multiple Myeloma, Paraproteinemias, Polyneuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡